Our expert analysts focus in on the latest advancements, key trends and takeaways from the Orthopedic Trauma Association (OTA) meeting in Tampa, Florida held October 12–15, 2022. Major trauma manufacturers showcased innovation through new product introductions.

Sofia Heddson Fransén, Essity’s Global Solution Owner, Intelligent Medical Solutions discusses the Company’s recent digital app launch as well as current and future trends in the digital field in an interview with SmartTRAK at SAWC Fall 2022.

Digital healthcare plays an increasingly important role in healthcare today. In the face of global concerns related to epidemics and pandemics, high costs and the effects of staff shortages, digital health-related technology continues to grow in importance and evolve. A broad scope of stakeholders are involved in the digital health field, including patients, practitioners, application developers and medical device manufacturers and distributors.

To find out more about Essity and the Company’s initiatives around digital solutions in wound care, click the video below to listen to the interview in which Sofia Heddson Fransén, Essity’s Global Solution Owner, Intelligent Medical Solutions, discusses the Company’s recent digital app launch and what the current and future trends in the digital field (05.33 min) are. A link to download the complete interview transcript is also provided below.

Dr. Kim outlines his extensive experience in adopting endoscopic spine surgery and reflects on barriers to widespread adoption, including the learning curve and reimbursement challenges

Endoscopic and arthroscopic technology has been around for a number of years, aiding surgeons’ visualization to treat patients in much less invasive ways than were previously possible. Prior to the introduction and adoption of these types of technology, surgeons were faced with invasive, more traumatic procedures and sometimes limitations on visualization based on anatomy. Less invasive approaches have allowed patients to benefit from less risk, shorter hospital stays and, in many cases, quicker healing.

Endoscopic approaches to spine surgery have been taking place for 10+ years, but the market hasn’t experienced transformative growth. All the patient benefits align with relative adoption trends, so why haven’t we seen endoscopic spine surgery grow at a similar rate? What does the future look like in this segment? SmartTRAKsat down with minimally invasive spine surgery pioneer Choll Kim, MD, PhD to explore his thoughts on focusing his minimally invasive surgical practice around specific offering of endoscopic spinal techniques, what the pros and cons have been within the adoption curve of the technology and where he thinks the market is headed.

SmartTRAK's spine experts will be roaming the floor at NASS 2022, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest news and innovations in the Spine Market and discuss how SmartTRAK can help you Be the Expert in your market.  If you would like to book a meeting with us at NASS, please click here.

Continue reading to find out how to download a complete transcript of SmartTRAK's interview with Dr. Kim.

SmartTRAK highlights key movements in the quickly changing landscape of interventional pain management and identifies practice trends surrounding SCS, PNS, minimally invasive spine and SI Joint Fusion from the recent ASPN and INS meetings.

Strong demand for alternatives to narcotic pain management combined with an aging population and growing incidence of chronic pain continue to drive demand for interventional pain techniques. The approach to the treatment of chronic intractable pain is evolving, with a shift toward data-focused treatment optimization, growing use of digital monitoring and holistic evaluation of patient outcomes. Furthermore, increasing overlap among various devices and therapies as well as unclear boundaries between interventional pain, orthopedic and spine practices is spurring physicians to adopt collaborative approaches to patient care.

Among the many timely topics covered in this comprehensive Market Outlook article "Pain Intervention: A Market of Moving Targets", which can be downloaded in its entirety here, are:

Adam Hattan, VP of Marketing for Route 92 Medical, discusses the Company, its novel system for mechanical thrombectomy and competing in the market for stroke interventions in an interview with SmartTRAK at SNIS 2022.

Amid a growing number of me-too devices, one company that is differentiating itself in the market for stroke thrombectomy is Route 92 Medical (R92). Adam Hattan, R92’s vice president of marketing, discusses R92’s novel system for mechanical thrombectomy and competing in the market for stroke interventions in an interview with SmartTRAK at the Society of Neurointerventional Surgery (SNIS) 19th Annual Meeting held in Toronto, Canada July 25-29, 2022.

To find out more about R92, its Monopoint operating platform and the Company’s strategies for growth, click on the following video recorded live at SNIS 2022.  (10:13 min). A link to download a transcript of the interview is also provided below.

Improved aspiration systems, large-bore catheters, balloon-guide catheters and radial access top the list of neurovascular device trends that will continue in 2022.

In the market for mechanical thrombectomy devices, the pace of innovation shows no signs of slowing down in 2022. Manufacturers are designing neurointerventional devices with an eye toward improving first-pass effect, recanalization rates and reducing procedure times to ultimately improve patient outcomes In this article, SmartTRAK highlights recent trends in neurovascular technologies, including variable pressure aspiration systems, large-bore catheters (LBCs), balloon-guide catheters (BGCs) and radial access, as key areas of innovation moving into 2022.

Along with the recent trends in neurovascular technologies, the following topics are covered in detail in this article, which is available for download here:

• Outgrowing Standard Aspiration Systems
• Continued Trend Toward Large-Bore Catheters for Access and Aspiration
• New Designs and Applications for Balloon-Guide Catheters
• Increasing Competition in Radial Access

Imagine if you could…

• See gaps in your product portfolio vs your competitors’ 
• Discover your next acquisition candidate
• Find a distribution partner

…in just a few clicks!

BE THE EXPERT who fills in the gaps in your company's portfolio! Read on to view a "How To" video and learn how to outperform your peers and competitors by saving yourself HOURS of research with just ONE search.

That’s the power of SmartTRAK!

For example…

Rafael Carbunaru, PhD, Boston Scientific’s VP of R&D, discusses DBS therapy and STIMVIEW XT, the Company’s new advanced visualization software for DBS programming, in an in-depth interview with SmartTRAK at INS 2022

Rafael Carbunaru, PhD, vice president of research and development for Boston Scientific (BSX), discusses deep brain stimulation (DBS) and STIMVIEW XT, the Company’s new advanced visualization software for DBS programming in an in-depth interview with SmartTRAK at the International Neuromodulation Society (INS) World Congress in Barcelona, Spain held May 21-26.

Used with the Vercise Genus DBS portfolio and developed in collaboration with Brainlab, STIMVIEW XT uses patient-specific 3D visualization of patient anatomy and enables clinicians to see, shape and steer DBS therapy using point-and-click interface designed to simplify programming, save time and better personalize therapy.

To find out more about STIMVIEW XT, DBS workflows and BSX’s vision for DBS, click on the following video to listen to the interview recorded live at INS 2022 (45:16 min). For more details, interview topics by timecode are provided below. A link to download a complete transcript of the interview is also available below.